Northwire Canada EditionSunday, October 18, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 100
  1. Nov 18, 2025 · 07:01 · VIVI

    TempraMed Announces Frankfurt Stock Exchange Listing and Corporate Awareness Agreement

    TempraMed Announces Frankfurt Stock Exchange Listing and Corporate Awareness Agreement

    01
  2. Nov 18, 2025 · 07:00 · HLS

    Esperion Partner HLS Therapeutics Announces Approval of NILEMDO(TM) for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease

    Esperion Partner HLS Therapeutics Announces Approval of NILEMDO(TM) for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease

    02
  3. Nov 18, 2025 · 07:00 · LSL

    LSL PHARMA GROUP COMPLETES THE ACQUISITION OF LABORATOIRE DU-VAR INC.

    LSL PHARMA GROUP COMPLETES THE ACQUISITION OF LABORATOIRE DU-VAR INC.

    03
  4. Nov 18, 2025 · 07:00 · ALGO

    Light AI Version 1.0 Software Completion

    Light AI Version 1.0 Software Completion

    04
  5. Nov 18, 2025 · 07:00 · MSCL

    Satellos Announces Publication in Nature Communications Supporting its Novel Treatment Approach for Duchenne Muscular Dystrophy

    Satellos Announces Publication in Nature Communications Supporting its Novel Treatment Approach for Duchenne Muscular Dystrophy

    05
  6. Nov 18, 2025 · 06:31 · FNDX

    FendX and Aquaox Sign MOU to Pursue Innovation in Sustainable Pathogen Elimination

    FendX and Aquaox Sign MOU to Pursue Innovation in Sustainable Pathogen Elimination

    06
  7. Nov 17, 2025 · 19:28 · SEGN

    Seegnal appoints Bibi-Aviv as CEO

    Seegnal appoints Bibi-Aviv as CEO

    07
  8. Nov 17, 2025 · 18:35 · MDP

    Medexus obtains $51-million (U.S.) credit, plans NCIB

    Medexus obtains $51-million (U.S.) credit, plans NCIB

    08
  9. Nov 17, 2025 · 18:18 · PHRM

    Pharmather Holdings signs evaluation deal with Oakwood

    Pharmather Holdings signs evaluation deal with Oakwood

    09
  10. Nov 17, 2025 · 16:31 · AGN

    Algernon signs contract, investment deal with AMI

    Algernon signs contract, investment deal with AMI

    10
  11. Nov 17, 2025 · 16:25 · TLT

    Theralase to host conference call Nov. 19

    Theralase to host conference call Nov. 19

    11
  12. Nov 17, 2025 · 16:15 · FRX

    Fennec Pharmaceuticals Announces Closing of Offering of Common Shares

    Fennec Pharmaceuticals Announces Closing of Offering of Common Shares

    12
  13. Nov 17, 2025 · 13:45 · KDA

    KDA GROUP OPENS A U.S. SUBSIDIARY AND ACCELERATES THE GROWTH OF ITS MEDHERIZE SOLUTION

    KDA GROUP OPENS A U.S. SUBSIDIARY AND ACCELERATES THE GROWTH OF ITS MEDHERIZE SOLUTION

    13
  14. Nov 17, 2025 · 09:43 · SEGN

    SEEGNAL INC. ANNOUNCES THE APPOINTMENT OF ELAD BIBI-AVIV AS NEW CHIEF EXECUTIVE OFFICER

    SEEGNAL INC. ANNOUNCES THE APPOINTMENT OF ELAD BIBI-AVIV AS NEW CHIEF EXECUTIVE OFFICER

    14
← Newer Older →